(Press-News.org) CHICAGO – Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA.
Clopidogrel is an antiplatelet drug used by approximately 40 million patients worldwide to treat or prevent atherothrombotic (blood clot from thickening of inner lining of arteries) events and after percutaneous coronary revascularization (such as balloon angioplasty). "Despite the overall benefit, some individuals may be less responsive to clopidogrel than others because clopidogrel is a prodrug activated by several enzymes, including CYP2C19, and common genetic variation in CYP2C19 alters enzyme activity," according to background information in the article. The American Heart Association and American College of Cardiologists have argued evidence is insufficient to support CYP2C19 genotype testing.
Michael V. Holmes, M.B.B.S., M.Sc., of University College London, and colleagues conducted a systematic review and meta-analysis to assess the strength and quality of evidence on the association of CYP2C19 genotype with responsiveness to clopidogrel. The researchers conducted a search of the medical literature and identified 32 studies that met criteria for inclusion. These included studies that reported clopidogrel metabolism, platelet reactivity or clinically relevant outcomes (cardiovascular disease [CVD] events and bleeding), and information on CYP2C19 genotype.
The 32 studies included 42,016 patients reporting 3,545 CVD events, 579 stent thromboses, and 1,413 bleeding events. Six studies were randomized trials ("effect-modification" design) and the remaining 26 reported individuals exposed to clopidogrel ("treatment-only" design). In treatment-only analysis, individuals with 1 or more CYP2C19 alleles (an alternative form of a gene) associated with lower enzyme activity had lower levels of active clopidogrel metabolites, less platelet inhibition, lower risk of bleeding, and higher risk of CVD events. However, there was evidence of small-study bias, the authors write. When analyses were restricted to studies with 200 or more events, the point estimate was lessened.
In effect-modification studies, CYP2C19 genotype was not associated with modification of the effect of clopidogrel on CVD end points or bleeding. A limitation included selective outcome reporting.
"Despite associations between CYP2C19 genotype, clopidogrel metabolism, and platelet aggregation, this systematic review and meta-analysis does not demonstrate a clinically important association of genotype with cardiovascular outcomes with the possible exception of stent thrombosis," the researchers write.
"Our appraisal has identified issues pertaining to the design and analysis of pharmacogenetic studies that are important in the understanding of the significance of the CYP2C19 genotype."
(JAMA. 2011;306[24]:2704-2714. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Pharmacogenomics and Clopidogrel - Irrational Exuberance?
Steven E. Nissen, M.D., of the Cleveland Clinic Foundation, writes in an accompanying editorial that several factors led to the unrealistic expectations of the effectiveness of CYP2C19 genotyping for clopidogrel, and that a large randomized controlled trial is needed to adequately test the clopidogrel pharmacogenomic hypothesis.
"In the absence of such a study, physicians should use CYP2C19 or platelet reactivity testing rarely, if ever, and interpret the results with caution. It is still likely that pharmacogenomics has a bright future in cardiovascular medicine, but the pharmacogenomics approach to drug therapy must undergo the same rigorous testing for efficacy and cost-effectiveness that is required for other therapies. Overzealous adoption based on limited biochemical data does not serve the public interest."
(JAMA. 2011;306[24]:2727-2728. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
To contact Michael V. Holmes, M.B.B.S., M.Sc., email mvholmes@gmail.com. To contact editorial author Steven E. Nissen, M.D., call Brian Kolonick at 216-225-5614 or email Kolonib@ccf.org.
### END
Analysis does not support genetic test before use of anti-clotting drug
2011-12-29
ELSE PRESS RELEASES FROM THIS DATE:
Possible Defenses To A DUI Charge
2011-12-29
You are sitting in your car, watching the red lights in your rearview mirror. The officer exits their vehicle and begins walking toward your car.
The next thing you know, you have been charged with a DUI. What do you do now?
You may think you have no chance, that even though you did not feel intoxicated or impaired, the blood alcohol content reading of the breathalyzer showed you were over the limit, and you are as good as convicted. Machines don't make mistakes, do they?
Challenging A DWI Charge
While it may seem an open and shut case, there may be multiple ...
Oxidative DNA damage repair
2011-12-29
Oxidative stress is the cause of many serious diseases such as cancer, Alzheimer's, arteriosclerosis and diabetes. It occurs when the body is exposed to excessive amounts of electrically charged, aggressive oxygen compounds. These are normally produced during breathing and other metabolic processes, but also in the case of ongoing stress, exposure to UV light or X-rays. If the oxidative stress is too high, it overwhelms the body's natural defences. The aggressive oxygen compounds destroy genetic material, resulting in what are referred to as harmful 8-oxo-guanine base mutations ...
Irikaitz archaeological site -- host to a 25,000-year-old pendant
2011-12-29
The recent discovery of a pendant at the Irikaitz archaeological site in Zestoa (in the Basque province of Gipuzkoa) has given rise to intense debate: it may be as old as 25,000 years, which would make it the oldest found to date at open-air excavations throughout the whole of the Iberian Peninsula. This stone is nine centimetres long and has a hole for hanging it from the neck although it would seem that, apart from being adornment, it was used to sharpen tools. The discovery has had great repercussion, but it is not by any means the only one uncovered here by the team ...
Whistleblowing Remedies in New Jersey
2011-12-29
Recent decisions by the New Jersey Supreme Court and the Appellate Division clarify the definition of "adverse employment action" that triggers New Jersey's "whistleblower law," known as the Conscientious Employee Protection Act (CEPA).
Adverse Employment Action
John Seddon had worked for Dupont 30 years when he filed a complaint with OSHA, the federal office for occupational safety and health. Seddon's complaint involved DuPont's practice of inspecting employee vehicles at the gate of the plant.
Employees had to stand by the side of a busy ...
Targeted blocking of cell death prevents fatal condition septic shock
2011-12-29
Ghent, Belgium 27 December 2011 - Researchers of VIB and UGent have discovered a new approach to preventing septic shock, an often fatal extreme inflammatory reaction of the body. It is the most frequent cause of death at intensive care departments in hospitals. In sepsis, acute inflammation is attended by low blood pressure and blood clots, causing the organs to stop working. Only recently, the Brazilian football legend Socrates, died of the consequences of this condition. In a new study in the top journal Immunity, Peter Vandenabeele and colleagues of VIB-UGent described ...
Toasting the chemistry of champagne: New Year's Eve video from the American Chemical Society
2011-12-29
WASHINGTON, Dec. 27, 2011 — Just in time for those New Year's Eve toasts, which might include a farewell to the International Year of Chemistry, the world's largest scientific society today posted online a video on the chemistry of champagne. The latest addition to the award-winning Bytesize Science series from the American Chemical Society (ACS) is available at www.BytesizeScience.com.
It explains that champagne, unlike other wines, undergoes a second fermentation in the bottle to trap carbon dioxide gas, which dissolves into the wine and forms the fabled bubbles in ...
Elderly can be as fast as young in some brain tasks, study shows
2011-12-29
COLUMBUS, Ohio – Both children and the elderly have slower response times when they have to make quick decisions in some settings.
But recent research suggests that much of that slower response is a conscious choice to emphasize accuracy over speed.
In fact, healthy older people can be trained to respond faster in some decision-making tasks without hurting their accuracy – meaning their cognitive skills in this area aren't so different from younger adults.
"Many people think that it is just natural for older people's brains to slow down as they age, but we're finding ...
Debt and Divorce
2011-12-29
According to a recent study in the Journal of Law, Economics and Organization reported more "households would benefit financially from bankruptcy than actually file." Although no one anticipates filing for bankruptcy, for some it is a viable option for future financial success.
The Wisconsin State Bar outlines the following benefits associated with bankruptcy:
- Keeping all or most property
- Easing credit card debts
- Avoiding certain liens and involuntary transfers
The Bar also cautions consideration of the disadvantages prior to filing. Including that ...
Children don't give words special power to categorize their world
2011-12-29
COLUMBUS, Ohio – New research challenges the conventional thinking that young children use language just as adults do to help classify and understand objects in the world around them.
In a new study involving 4- to 5-year-old children, researchers found that the labels adults use to classify items – words like "dog" or "pencil" – don't have the same ability to influence the thinking of children.
"As adults, we know that words are very predictive. If you use words to guide you, they won't often let you down," said Vladimir Sloutsky, co-author of the new study and professor ...
Mutation in gene that's critical for human development linked to arrhythmia
2011-12-29
(SALT LAKE CITY)— Arrhythmia is a potentially life-threatening problem with the rate or rhythm of the heartbeat, causing it to go too fast, too slow or to beat irregularly. Arrhythmia affects millions of people worldwide.
The cardiac conduction system (CCS) regulates the rate and rhythm of the heart. It is a group of specialized cells in the walls of the heart. These cells control the heart rate by sending electrical signals from the sinoatrial node in the heart's right atrium (upper chamber) to the ventricles (lower chambers), causing them to contract and pump blood.
The ...